We are live on ! Find out more
ICP

Interchange Capital Partners Portfolio holdings

AUM $532M
1-Year Est. Return 26.57%
This Fund
S&P 500
This Quarter Est. Return
+20.21%
1 Year Est. Return
+26.57%
3 Year Est. Return
+79.59%
5 Year Est. Return
+78.72%
10 Year Est. Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$172M
Cap. Flow %
93.32%
Top 10 Hldgs %
18.83%
Holding
1,243
New
1,241
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$4.72M
2
AAPL icon
Apple
AAPL
+$4.29M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$3.9M
4
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$3.64M
5
VTV icon
Vanguard Value ETF
VTV
+$3.55M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 15.67%
2 Healthcare 13.87%
3 Consumer Discretionary 9.11%
4 Financials 7.57%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ET icon
1076
Energy Transfer Partners
ET
$69.5B
$2K ﹤0.01%
+391
New +$2.37K
EVH icon
1077
Evolent Health
EVH
$371M
$2K ﹤0.01%
+132
New +$1.75K
FMX icon
1078
Fomento Económico Mexicano
FMX
$41.2B
$2K ﹤0.01%
+35
New +$2.34K
FN icon
1079
Fabrinet
FN
$14.9B
$2K ﹤0.01%
+38
New +$2.58K
GNRC icon
1080
Generac Holdings
GNRC
$11.5B
$2K ﹤0.01%
+10
New +$2.15K
GO icon
1081
Grocery Outlet
GO
$904M
$2K ﹤0.01%
+69
New +$2.79K
HALO icon
1082
Halozyme
HALO
$9.88B
$2K ﹤0.01%
+54
New +$1.94K
HES
1083
DELISTED
Hess
HES
$2K ﹤0.01%
+56
New +$2.54K
HPP
1084
Hudson Pacific Properties
HPP
$758M
$2K ﹤0.01%
+18
New +$2.97K
ING icon
1085
ING
ING
$92.9B
$2K ﹤0.01%
+220
New +$1.89K
INSM icon
1086
Insmed
INSM
$22.4B
$2K ﹤0.01%
+71
New +$2.59K
INSP icon
1087
Inspire Medical Systems
INSP
$1.47B
$2K ﹤0.01%
+12
New +$1.96K
IOVA icon
1088
Iovance Biotherapeutics
IOVA
$2.04B
$2K ﹤0.01%
+51
New +$2.02K
IRWD icon
1089
Ironwood Pharmaceuticals
IRWD
$586M
$2K ﹤0.01%
+193
New +$2.11K
JBL icon
1090
Jabil
JBL
$30.1B
$2K ﹤0.01%
+52
New +$1.97K
KKR icon
1091
KKR & Co
KKR
$89.1B
$2K ﹤0.01%
+50
New +$1.89K
KPTI icon
1092
CALL
Karyopharm Therapeutics
KPTI
$155M
– –
0
– –
LOPE icon
1093
Grand Canyon Education
LOPE
$4.22B
$2K ﹤0.01%
+30
New +$2.56K
MARA icon
1094
Marathon Digital Holdings
MARA
$3.83B
$2K ﹤0.01%
+250
New +$1.15K
MMM icon
1095
3M
MMM
$91.8B
$2K ﹤0.01%
+19
New +$2.7K
MTRN icon
1096
Materion
MTRN
$3.94B
$2K ﹤0.01%
+32
New +$1.84K
NVMI
1097
Nova
NVMI
$11.7B
$2K ﹤0.01%
+35
New +$2.18K
OSK icon
1098
Oshkosh
OSK
$8.91B
$2K ﹤0.01%
+33
New +$2.63K
PFBC icon
1099
Preferred Bank
PFBC
$1.24B
$2K ﹤0.01%
+53
New +$2.07K
RUSHA icon
1100
Rush Enterprises Class A
RUSHA
$6.34B
$2K ﹤0.01%
+89
New +$2.28K
42 43
44
45 46

Similar funds

KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
UFF
USA Financial Formulas Ada, Michigan $531M AUM 28.6% 1-Year Est. Return
EPA
Element Pointe Advisors Miami, Florida $530M AUM 16.87% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
OMC
Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Interchange Capital Partners's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Interchange Capital Partners, which disclosed 1,243 positions worth $184M. Its ten largest holdings account for 19% of the portfolio.

Its largest position is iShares Gold Trust: 131,924 shares worth $4.78M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, followed by Healthcare and Consumer Discretionary.

  • Interchange Capital Partners's largest Q4 2020 buy was iShares Gold Trust: 131,924 shares worth $4.78M.
  • Interchange Capital Partners's ten largest holdings make up 19% of its $184M portfolio in Q4 2020.
  • Interchange Capital Partners disclosed 1,243 positions in Q4 2020, its first 13F filing on record.

Based on Interchange Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.